Dyne Therapeutics
124 hedge funds and large institutions have $957M invested in Dyne Therapeutics in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
19.06% more ownership
Funds ownership: 98.15% → 117.21% (+19%)
9% more funds holding
Funds holding: 114 → 124 (+10)
8% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 40
Holders
124
Holding in Top 10
4
Calls
$16M
Puts
$5.78M
Top Buyers
| 1 | +$52.3M | |
| 2 | +$15.8M | |
| 3 | +$12M | |
| 4 |
BlackRock
New York
|
+$6.41M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.8M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$5.78M | |
| 3 | -$5.37M | |
| 4 |
AC
Armistice Capital
New York
|
-$5M |
| 5 |
Goldman Sachs
New York
|
-$4.62M |